Biblio
“Dementia Care in Times of COVID-19: Experience at Fundació ACE in Barcelona, Spain.”, J Alzheimers Dis, vol. 76, no. 1, pp. 33-40, 2020.
, “Longitudinal Neuroimaging Analysis in Mild-Moderate Alzheimer's Disease Patients Treated with Plasma Exchange with 5% Human Albumin.”, J Alzheimers Dis, vol. 61, no. 1, pp. 321-332, 2018.
, “Patient Engagement: The Fundació ACE Framework for Improving Recruitment and Retention in Alzheimer's Disease Research.”, J Alzheimers Dis, vol. 62, no. 3, pp. 1079-1090, 2018.
, “The Role of Verb Fluency in the Detection of Early Cognitive Impairment in Alzheimer's Disease.”, J Alzheimers Dis, vol. 62, no. 2, pp. 611-619, 2018.
, “Cognitive Composites Domain Scores Related to Neuroimaging Biomarkers within Probable-Amnestic Mild Cognitive Impairment-Storage Subtype.”, J Alzheimers Dis, vol. 57, no. 2, pp. 447-459, 2017.
, “Efficacy and Safety of Plasma Exchange with 5% Albumin to Modify Cerebrospinal Fluid and Plasma Amyloid-β Concentrations and Cognition Outcomes in Alzheimer's Disease Patients: A Multicenter, Randomized, Controlled Clinical Trial.”, J Alzheimers Dis, vol. 56, no. 1, pp. 129-143, 2017.
, “Impact of Recruitment Methods in Subjective Cognitive Decline.”, J Alzheimers Dis, vol. 57, no. 2, pp. 625-632, 2017.
, “Social Representation of Dementia: An Analysis of 5,792 Consecutive Cases Evaluated in a Memory Clinic.”, J Alzheimers Dis, vol. 58, no. 4, pp. 1099-1108, 2017.
, “Beneficial Effects of an Integrated Psychostimulation Program in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 50, no. 2, pp. 559-66, 2016.
, “MAPT H1 Haplotype is Associated with Late-Onset Alzheimer's Disease Risk in APOEɛ4 Noncarriers: Results from the Dementia Genetics Spanish Consortium.”, J Alzheimers Dis, vol. 49, no. 2, pp. 343-52, 2016.
,